Bruges, Belgium

Maryvonne Rosseneu

This inventor holds 1 USPTO granted patent. Top assignee: N.v. Innogenetics S.a.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maryvonne Rosseneu. Retrieved from https://idiyas.com/inventor/maryvonne-rosseneu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Maryvonne Rosseneu - Innovator in Peptide and Protein Technologies**

Introduction

Maryvonne Rosseneu is a prominent inventor based in Brugge, Belgium. She holds a significant patent in the field of biochemistry, specifically related to peptides and proteins. Her contributions are noteworthy in advancing the science of protein preparation and utilization.

Latest Patents

Maryvonne Rosseneu has one recorded patent that focuses on "Peptides and proteins, process for their preparation and their use." This patent showcases her innovative approach to developing processes that enhance the versatility and application of these essential biological compounds.

Career Highlights

Maryvonne currently works with N.V. Innogenetics S.A., a company well-regarded for its commitment to advancing biotechnology. Under her expertise, the company has made strides in the development of medical diagnostics and therapeutic solutions.

Collaborations

Throughout her career, Maryvonne has collaborated with esteemed colleagues, including Robert Brasseur and Robert J. Deleys. These partnerships have contributed to her research endeavors and the successful implementation of her innovations in the field.

Conclusion

Maryvonne Rosseneu exemplifies the dedication and creativity found within the scientific community. Her work in peptides and proteins not only reflects her personal achievements but also contributes significantly to advancements in biotechnology, paving the way for future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…